Summary & Overview
CPT 20205: Deep Muscle Biopsy for Diagnostic Analysis
CPT code 20205 identifies a deep muscle biopsy, a surgical diagnostic procedure to obtain tissue from muscle located well below the fascia or beneath other muscles or bones. This procedure is clinically important for diagnosing inflammatory myopathies, muscular dystrophies, metabolic myopathies, and infectious or infiltrative processes that cannot be assessed by less invasive sampling. Nationally, deep muscle biopsy carries implications for procedural coding consistency, facility setting and resource use, and payer coverage policies for diagnostic surgical procedures.
Key payers in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise briefing on the clinical context and typical sites of service, plus an overview of expected documentation elements and billing considerations tied to deep muscle biopsy procedures. The publication highlights common modifier usage and payer coverage patterns where available, and outlines benchmarking topics such as allowed services, place-of-service implications, and typical care pathways for surgical diagnostic biopsies.
This summary serves clinicians, coding professionals, and policy analysts seeking a national-level reference for CPT code 20205—covering what the code represents, why it matters for diagnosis and coverage decisions, and the practical topics to review when managing billing and utilization for deep muscle biopsy services.
Billing Code Overview
CPT code 20205 describes a muscle biopsy of deep muscle tissue, a procedure to obtain a sample of muscle well below the fascia or beneath other muscles or bones for diagnostic analysis of suspected medical conditions or infections. This service requires tissue sampling from deep muscular structures rather than superficial or subcutaneous tissue.
-
Service type: Surgical diagnostic procedure (deep muscle biopsy)
-
Typical site of service: Hospital operating room or ambulatory surgery center; may occur in a procedure room when appropriate imaging and anesthesia support are available.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 48-year-old patient presents with progressive, symmetric proximal muscle weakness, elevated serum creatine kinase, and electromyography findings suggestive of an inflammatory myopathy. After noninvasive testing (laboratory studies, EMG, and imaging) is inconclusive for a specific etiology, the neuromuscular specialist schedules a deep muscle biopsy to obtain tissue below the fascia for histopathology, immunohistochemistry, and microbiologic studies. The procedure is performed in an outpatient surgical suite or hospital operating room under monitored anesthesia care or general anesthesia depending on patient comorbidity and muscle depth. The surgeon selects an accessible, clinically involved muscle (often quadriceps or deltoid), obtains a core or open biopsy including deep muscle tissue, ensures adequate hemostasis, and places specimens in appropriate media (formalin for histology, fresh frozen for enzyme/histochemistry, sterile container for culture) before sending to the pathology laboratory. Post-procedure care includes wound checks, short observation for anesthesia recovery, activity restrictions to reduce bleeding risk, and pathology follow-up for definitive diagnosis and targeted therapy planning.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | Use when only the professional interpretation component is billed separately by the physician when applicable (e.g., pathology interpretation billed separately from facility) |
51 | Multiple procedures | Use when additional distinct surgical procedures are performed in the same operative session |
52 | Reduced services | Use when the biopsy is attempted but not completed or is abbreviated compared with full procedure |
53 | Discontinued procedure | Use when the biopsy is terminated due to extenuating circumstances or complications |
59 | Distinct procedural service | Use to indicate a separate and distinct procedure at a separate anatomic site or session |
62 | Two surgeons | Use when a co-surgeon is required for complex exposure or patient factors |
66 | Surgical team | Use when a surgical team approach is required for complex cases |
76 | Repeat procedure by same physician | Use when the same physician repeats the biopsy procedure later during the same course of treatment |
77 | Repeat procedure by another physician | Use when a second physician repeats the biopsy |
78 | Return to operating room for a related procedure during the postoperative period | Use when surgical revision or complication management requires return to the OR |
80 | Assistant surgeon | Use when an assistant surgeon performs part of the procedure |
AS | Physician assistant, nurse practitioner, or clinical nurse specialist services for assistant at surgery | Use when an advanced practice clinician assists in surgery and the payor accepts AS |
LT | Left side | Use to identify laterality when applicable to payer rules |
RT | Right side | Use to identify laterality when applicable to payer rules |
| Taxonomy Code | Specialty | Notes |
|---|---|---|
| 207RC0000X | Physical Medicine & Rehabilitation | Clinicians involved in neuromuscular diagnosis and coordination of biopsy |
| 207XS0103X | Neurology | Neuromuscular specialists who evaluate and refer for biopsy |
| 208600000X | General Surgery | Surgeons who perform open or deep muscle biopsies |
| 207L00000X | Pathology | Pathologists who interpret biopsy specimens and provide diagnostic reports |
| 364S00000X | Vascular Surgery | Occasionally involved when access or complex exposure is required |
Related Diagnoses
| ICD-10 Code | Description | Clinical Relevance |
|---|---|---|
M60.9 | Myositis, unspecified | Common indication for deep muscle biopsy to confirm inflammatory myopathy |
M33.9 | Dermatopolymyositis, unspecified | Deep muscle biopsy can help distinguish polymyositis/dermatomyositis |
G72.0 | Infantile spinal muscular atrophy and related syndromes | Muscle biopsy may be used in certain neuromuscular diagnostic evaluations |
G71.3 | Mitochondrial myopathy, not elsewhere classified | Biopsy for histochemistry and mitochondrial studies |
A49.9 | Bacterial infection, unspecified | Muscle biopsy may be obtained for suspected infectious myositis |
M79.1 | Myalgia | When persistent, biopsy may be used to evaluate underlying pathology |
R53.83 | Other fatigue | As part of a workup for unexplained weakness and fatigue where muscle disease is suspected |
Related CPT Codes
| CPT Code | Description | Relationship to This Procedure |
|---|---|---|
20206 | Biopsy, muscle, deep with nerve; single muscle, with or without image guidance | Alternative/additional code when nerve sampling is included with the deep muscle biopsy |
20207 | Biopsy, muscle, deep with nerve; more than one muscle, with or without image guidance | Use when multiple deep muscle sites and nerve sampling are performed |
20220 | Biopsy, muscle, open; superficial muscle | Related superficial muscle biopsy code when less deep tissue is required |
10021 | Fine needle aspiration; without imaging guidance | May be performed prior to deep biopsy for cytologic evaluation when applicable |
20999 | Unlisted procedure, musculoskeletal system | Used for atypical or experimental biopsy techniques not described by existing codes |
87070 | Culture, bacterial; any other source, quantitative or semi-quantitative, each organism identified | Laboratory code commonly used for microbiologic culture of biopsy specimens |